be_ixf;ym_202404 d_27; ct_50
NYSE:CRS charts & data provided by TradingView

Latest Insights on CRS

Maybe past performance won’t tell us exactly what will happen in the future. But it does show us that owning this asset is the right thing to do. This Super Asset Dominated the Past 15 Years
by Brian Christopher July 11, 2019 Investing, Stocks, Winning Investor Daily
Maybe past performance won’t tell us exactly what will happen in the future. But it does show us that owning this asset is the right thing to do.
Outdated Electric Grid How High-Tech Homeowners Are Slashing Energy Costs
by Ian Dyer June 12, 2018 Economy
We’re talking about huge, sustained growth in a technology that’s now becoming more appealing for more people. And investing in this trend could offer huge returns.
If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases. Gene Editing: The Cure for Every Disease?
by Ian Dyer November 2, 2017 Investment Opportunities
If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases.
Stopping the Cybersecurity ‘Spiral of Death’
by Jeff Yastine October 31, 2017 Investment Opportunities
We can learn plenty about where the cybersecurity world is headed by following a lesson from history: More automation. Fewer people. Fewer problems.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

Share This